COMMON STOCK PURCHASE WARRANTCommon Stock Purchase • November 9th, 2005 • Clarient, Inc • Laboratory analytical instruments
Contract Type FiledNovember 9th, 2005 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT CERTIFIES that, for value received, (the “Holder”), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after November 9, 2005 (the “Initial Exercise Date”) and on or prior to the close of business on November 9, 2009 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Clarient, Inc., a corporation incorporated in the State of Delaware (the “Company”), up to shares (the “Warrant Shares”) of Common Stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock (the “Exercise Price”) under this Warrant shall be $1.35, subject to adjustment hereunder. The Exercise Price and the number of Warrant Shares for which the Warrant is exercisable shall be subject to adjustment as provided herein. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain S
CLARIENT, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 9th, 2005 • Clarient, Inc • Laboratory analytical instruments • New York
Contract Type FiledNovember 9th, 2005 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 8, 2005, among Clarient, Inc., a Delaware corporation (the “Company”), and the purchasers identified on the signature pages hereto (each a “Purchaser” and collectively the “Purchasers”); and
CLARIENT, INC. Registration Rights AgreementRegistration Rights Agreement • November 9th, 2005 • Clarient, Inc • Laboratory analytical instruments • New York
Contract Type FiledNovember 9th, 2005 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of November 8, 2005, by and among Clarient, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).